Next Article in Journal
Identification and Validation of ERK5 as a DNA Damage Modulating Drug Target in Glioblastoma
Next Article in Special Issue
The Role of Rituximab in the Treatment of Primary Central Nervous System Lymphoma
Previous Article in Journal
Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis
 
 
Article

Article Versions Notes

Cancers 2021, 13(5), 943; https://doi.org/10.3390/cancers13050943
Action Date Notes Link
article pdf uploaded. 24 February 2021 12:03 CET Version of Record https://www.mdpi.com/2072-6694/13/5/943/pdf-vor
article supplementary file uploaded. 24 February 2021 12:03 CET - https://www.mdpi.com/2072-6694/13/5/943#supplementary
article xml file uploaded 1 March 2021 10:23 CET Original file -
article xml uploaded. 1 March 2021 10:23 CET Update https://www.mdpi.com/2072-6694/13/5/943/xml
article pdf uploaded. 1 March 2021 10:23 CET Updated version of record https://www.mdpi.com/2072-6694/13/5/943/pdf
article html file updated 1 March 2021 10:25 CET Original file -
article html file updated 25 July 2022 04:49 CEST Update https://www.mdpi.com/2072-6694/13/5/943/html
Back to TopTop